Salem Investment Counselors Inc Armata Pharmaceuticals, Inc. Transaction History
Salem Investment Counselors Inc
- $2.81 Billion
- Q1 2025
A detailed history of Salem Investment Counselors Inc transactions in Armata Pharmaceuticals, Inc. stock. As of the latest transaction made, Salem Investment Counselors Inc holds 100 shares of ARMP stock, worth $188. This represents 0.0% of its overall portfolio holdings.
Number of Shares
100
Previous 100
-0.0%
Holding current value
$188
Previous $0
NaN%
% of portfolio
0.0%
Previous 0.0%
Shares
1 transactions
Others Institutions Holding ARMP
# of Institutions
28Shares Held
740KCall Options Held
300Put Options Held
1K-
Vanguard Group Inc Valley Forge, PA260KShares$488,9370.0% of portfolio
-
Geode Capital Management, LLC Boston, MA106KShares$198,9730.0% of portfolio
-
Edgewood Management LLC Greenwich, CT100KShares$188,0000.0% of portfolio
-
Bridgeway Capital Management, LLC Houston, TX44.7KShares$84,0020.0% of portfolio
-
State Street Corp Boston, MA40.3KShares$75,7640.0% of portfolio
About Armata Pharmaceuticals, Inc.
- Ticker ARMP
- Exchange NYSE
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 36,144,700
- Market Cap $68M
- Description
- Armata Pharmaceuticals, Inc., a clinical-stage biotechnology company, focuses on the development of targeted bacteriophage therapeutics for antibiotic-resistant infections worldwide. It develops its products using its proprietary bacteriophage-based technology. The company's product candidates include AP-SA02 for the treatment of Staphylococcus ...